Philadelphia, PA, London, UK, February 28, 2012 – Thomson Reuters announced the availability of Cortellis for Informatics – its new solution providing web services that speed access to critical life sciences R&D information on its premiere life sciences platform, Thomson Reuters Cortellis. These application programming interfaces (APIs) are designed to enhance the research and development process by delivering seamless, real-time access to the most powerful information and tools for biopharmaceutical competitive intelligence, drug pipeline, and drug research and development available.
The APIs offer a new way to access high quality Thomson Reuters pharmaceutical content beyond a traditional interface. Each API integrates Thomson Reuters data with proprietary content and public information sources into a single comprehensive view that is customized based on the needs of a company, team or individual researcher. Data can be shared in a number of different ways, including dashboards, custom reports and alerts, and intranet and mobile applications.
“We worked closely with Thomson Reuters during their development and testing phases, and I am delighted to say that the Cortellis APIs exceed my expectations and allow us to take advantage of Thomson Reuters content in the systems that drive our business,” said Dr. William Hayes, director of decision support at Biogen Idec.
“For life sciences professionals, Cortellis for Informatics is a significant step forward,” said Wendy Hamilton, senior vice president at Thomson Reuters. “The advanced options for obtaining information give customers access to our content beyond Cortellis’ highly intuitive web portal. Information can now be incorporated directly on the user’s preferred systems, customized to their needs, creating additional opportunities for integration across the entire organization.”
Cortellis for Informatics streamlines information sharing across all levels of the organization. Instead of using multiple systems to manage workflows, users can access up-to-the-minute news in the office, in meetings or at the bench. The ability to deploy high quality Thomson Reuters information across the whole company in real time within internal systems provides greater opportunities for collaboration in the scientific search and discovery process.
Cortellis for Informatics provides web services for investigational drugs, drug targets, ontologies, patents, clinical trials and analytics.
For more information on Cortellis, visit cortellis.thomsonreuters.com.
About Thomson Reuters
Thomson Reuters is the world’s leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world’s most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.
